Papers by Merve Emecen Sanli
Journal of Pediatric Endocrinology and Metabolism, Feb 18, 2022
Objectives Fructose 1,6 bisphosphatase (FBPase) deficiency is a rare autosomal recessively inheri... more Objectives Fructose 1,6 bisphosphatase (FBPase) deficiency is a rare autosomal recessively inherited metabolic disease. It is encoded by FBP1, and the enzyme catalyzes the hydrolysis of fructose-1,6-bisphosphate to fructose 6-phosphate. Patients with recurrent episodes of metabolic acidosis, hypoglycemia, hypertriglyceridemia, and hyperketonemia are present. Methods In this study, we describe the clinical, biochemical, and molecular genetic features of six unrelated Turkish patients from six different families who were genetically diagnosed with FBPase deficiency in our clinic between 2008 and 2020. Their clinical and laboratory data were collected retrospectively. Next-generation sequencing (NGS) was performed for the molecular genetic analysis. Results All patients were hospitalized with recurrent hypoglycemia and metabolic acidosis episodes. Three out of six patients were presented in the neonatal period. The mean age at diagnosis was 26 months. NGS revealed a known homozygous gross deletion including exon 2 in three patients (50%), a known homozygous c.910_911dupTT pathogenic variant in one patient (16%), a novel homozygous c.651_653delCAGinsTAA likely pathogenic variant, and another novel homozygous c.705+5G>A splice site variant. Leukocyte FBPase analysis detected no enzyme activity in the patient with homozygous c.705+5G>A splice site variant. Conclusions We identified two novel mutations in this study. One of them is a splice site mutation which is five bases downstream of the exon, and the other one is an indel mutation. Both of the splice site and indel mutations are exceedingly rare in FBP1, and to the best of our knowledge, there are second splice site and indel variants reported in the literature. Exon 2 deletion is the most common mutation consistent with the previous reports in Turkish patients. FBPase is a frequent cause of hypoglycemia and metabolic acidosis, and the widespread use of molecular genetic analysis would contribute to the enlightenment of advanced genetic factors and possible genotype/phenotype correlation.
Bookmarks Related papers MentionsView impact
Turkish Journal of Pediatrics, 2022
Bookmarks Related papers MentionsView impact
Journal of Pediatric Endocrinology and Metabolism
Objectives Fabry disease is an X-linked lysosomal disorder caused by decreased or absent alpha ga... more Objectives Fabry disease is an X-linked lysosomal disorder caused by decreased or absent alpha galactosidase enzyme. The enzyme deficiency leads to progressive accumulation of globotriaosylceramide (Gb-3) and its deacetylated form lyso-Gb3 in various tissue lysosomes that results in primarily lysosomal deterioration and subsequently mitochondrial, endothelial, and immunologic dysfunctions. Methods The endocrinological, metabolic, immunological and HLA status of 12 patients were evaluated. Results A total of 11 patients (91.6 %) had immunologic and/or endocrinologic abnormalities. fT4, anti-TPO, and anti-TG levels were increased in 1, 2, and 2 patients, respectively. Three patients had elevated proinflammatory cytokines. ANA profile, p-ANCA and c-ANCA were positive in 1, 1, and 2 patients, respectively. Tissue transglutaminase antibody was negative in all patients however P5 was diagnosed with Celiac disease at the age of 12 and on gluten free diet. All patients had distinct types of...
Bookmarks Related papers MentionsView impact
Journal of Pediatric Endocrinology and Metabolism, 2022
Objectives Fructose 1,6 bisphosphatase (FBPase) deficiency is a rare autosomal recessively inheri... more Objectives Fructose 1,6 bisphosphatase (FBPase) deficiency is a rare autosomal recessively inherited metabolic disease. It is encoded by FBP1, and the enzyme catalyzes the hydrolysis of fructose-1,6-bisphosphate to fructose 6-phosphate. Patients with recurrent episodes of metabolic acidosis, hypoglycemia, hypertriglyceridemia, and hyperketonemia are present. Methods In this study, we describe the clinical, biochemical, and molecular genetic features of six unrelated Turkish patients from six different families who were genetically diagnosed with FBPase deficiency in our clinic between 2008 and 2020. Their clinical and laboratory data were collected retrospectively. Next-generation sequencing (NGS) was performed for the molecular genetic analysis. Results All patients were hospitalized with recurrent hypoglycemia and metabolic acidosis episodes. Three out of six patients were presented in the neonatal period. The mean age at diagnosis was 26 months. NGS revealed a known homozygous gr...
Bookmarks Related papers MentionsView impact
Indian Journal of Pediatrics, 2021
To the Editor: There are limited number of patients with congenital analbuminemia (CAA) with lipo... more To the Editor: There are limited number of patients with congenital analbuminemia (CAA) with lipodystrophy in the literature and all of them have edema. An 8-y-old girl was admitted due to swelling of the fat tissues affecting the lower extremities without edema. Laboratory evaluation showed marked hypoalbuminemia (0.19 g/dL, normal range: 3.63– 4.91), and significant increase in low-density lipoprotein cholesterol (355 mg/dL, normal range: 0–130) and total cholesterol (443.6 mg/dL, normal range: 0–200). Serum protein electrophoresis revealed the near absence of an albumin peak and compensatory increase in other proteins. The patient also had remarkable elevations in lipoprotein(a) and transferrin, suggesting CAA. Molecular analysis of the ALB gene showed a homozygous mutation previously defined as IVS1+1G>T (c.79+1G>T) studied by Sanger sequencing and confirmed with parental segregation [1]. A newborn premature baby who had respiratory distress syndrome and later on had pulmo...
Bookmarks Related papers MentionsView impact
Ege Tıp Dergisi
Bookmarks Related papers MentionsView impact
Objectives Familial hyperphosphatemic tumoral calcinosis is a rare disorder characterized by hype... more Objectives Familial hyperphosphatemic tumoral calcinosis is a rare disorder characterized by hyperphosphatemia with recurrent ectopic periarticular calcifications, in addition to other visceral and vascular manifestations, without any inflammatory or neoplastic disorder. The available treatment strategies are limited. Here we report an eight year old female patient with recurrent lesions under the chin, and bilateral hips which are painful and improving of the size of the lesions and hyperphosphatemia. Case presentation The patient was started to the treatment with peroral acetazolamide however the lesion did not regress but a new lesion appeared then we added sevelamer and topical sodium thiosulfate treatment for three months. After the three months of the combination treatment the lesions, there were no pain, no hyperphospahtemia regression/disappearance of the lesions. Conclusions This combination treatment or topical sodium thiosulfate use only may be a novel treatment strategy ...
Bookmarks Related papers MentionsView impact
Journal of Pediatric Endocrinology and Metabolism
Objectives Enzyme replacement therapy (ERT) with alglucosidase alfa (rhGAA) has changed the fatal... more Objectives Enzyme replacement therapy (ERT) with alglucosidase alfa (rhGAA) has changed the fatal course of infantile Pompe disease, however, development of anti rhGAA antibodies and infusion-associated reactions (IAR) restrict the tolerability and effectiveness of the treatment. Case presentation We describe a successful concomitant immune tolerance induction (ITI) and desensitization protocols in a cross-reactive immunologic material (CRIM) negative 7-month-old male patient. At the age of 5 months and eighth dose of the ERT, the patient developed IAR and his rhGAA specific IgE was negative however, his rhGAA specific IgG titer was as high as 12,800. ITI therapy to suppress antibody formation and a desensitization protocol was devised to be given concomitantly. At the end of 5-week therapy, his fatigue and weakness improved profoundly and a control antidrug antibody level decreased at 800. At the time of the patient’s follow up, he was still on ERT with desensitization at the age o...
Bookmarks Related papers MentionsView impact
Journal of the Endocrine Society
Context: Autosomal-recessive mutations in the growth hormone receptor (GHR) are the most common c... more Context: Autosomal-recessive mutations in the growth hormone receptor (GHR) are the most common causes for primary growth hormone insensitivity (GHI) syndrome with classical GHI phenotypically characterized by severe short stature and marked insulin-like growth factor (IGF)-I deficiency. We report three families with dominant-negative heterozygous mutations in the intracellular domain of the GHR causing a nonclassical GHI phenotype. Objective: To determine if the identified GHR heterozygous variants exert potential dominant-negative effects and are the cause for the GHI phenotype in our patients. Results: All three mutations (c.964dupG, c.920_921insTCTCAAAGATTACA, and c.945+2T>C) are predicted to result in frameshift and early protein termination. In vitro functional analysis of variants c.964dupG and c.920_921insTCTCAAAGATTACA (c.920_921ins14) suggests that these variants are expressed as truncated proteins and, when coexpressed with wild-type GHR, mimicking the heterozygous sta...
Bookmarks Related papers MentionsView impact
Pakistan Journal of Medical Sciences, 1969
Bookmarks Related papers MentionsView impact
Pakistan Journal of Medical Sciences, 1969
Bookmarks Related papers MentionsView impact
Uploads
Papers by Merve Emecen Sanli